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Compensatory mutations offset fitness defects resulting from CD8
؉ T lymphocyte (CD8 TL )-mediated escape, but their impact on viral evolution following transmission to naive hosts remains unclear. Here, we investigated the reversion kinetics of Gag 181-189 CM9 CD8 TL escape-associated compensatory mutations in simian immunodeficiency virus (SIV)-infected macaques. Preexisting compensatory mutations did not result in acute-phase escape of the SIVmac239 CD8TL epitope Gag181-189CM9 and instead required a tertiary mutation for stabilization in the absence of Gag 181-189 CM9 escape mutations. Therefore, transmitted compensatory mutations do not necessarily predict rapid CD8 TL escape.
R eversion of particular CD8
ϩ T lymphocyte (CD8 TL ) escape mutations is well documented following human immunodeficiency virus (HIV) transmission between HLA-discordant individuals and is dependent upon the fitness cost of the escape mutation. Escape mutations that exact a high fitness cost often revert following HIV transmission to an HLA-discordant individual, while those that impose a low fitness cost do not (1) (2) (3) . Two epitopes targeted by CD8 TL responses associated with long-term HIV control, HLA-B*27-bound Gag 263-272 KK10 and HLA-B*57-bound Gag 240 -249 TW10, lie within a conserved region of Gag, and escape mutations within these epitopes reduce viral fitness. However, while the codon 242 threonine-to-asparagine (T 242 N) escape mutation within Gag 240 -249 TW10 reverts readily following transmission to an HLA-disparate host, the R 264 K escape mutation within Gag 263-272 KK10 does not (3, 4) . This finding is surprising given that the R 264 K mutation reduces viral replicative fitness to a significantly greater extent than the T 242 N mutation (5) . Compensatory mutations that maintain viral fitness while allowing for intraepitopic variation have been described for both Gag 263-272 KK10 and Gag 240 -249 TW10, and the difference in reversion kinetics between these epitopes is likely dependent on these compensatory mutations (4, 6, 7) .
In simian immunodeficiency virus mac239 (SIVmac239)-infected rhesus macaques, the Mamu-A1*001:01-bound CD8 TL epitope Gag 181-189 CM9 is analogous to Gag 263-272 KK10 and Gag 240 -249 TW10 in that it lies within a conserved region of Gag and has associated compensatory mutations that increase the fitness of viral variants containing Gag 181-189 CM9 escape mutations. We, and others, have previously shown that the canonical Gag 181-189 CM9 escape mutation T 182 A is frequently linked with the flanking downstream mutation I 206 V and reverts following transmission to Mamu-A1*001:01-negative rhesus macaques (8) (9) (10) . Additionally, the I 206 V compensatory mutation is consistently associated with a subsequent upstream mutation, I 161 V. This mutation is not necessary for the emergence of viruses with the T 182 A escape mutation, but it is believed to further increase viral fitness following mutations at both T 182 and I 206 .
We hypothesized that preexisting I 161 V and I 206 V compensatory mutations would facilitate rapid, acute-phase escape within the conserved Gag 181-189 CM9 CD8 TL epitope upon transmission to Mamu-A1*001:01-positive rhesus macaques. To test this hypothesis, we engineered an SIVmac239 variant harboring the I 161 V and I 206 V compensatory mutations associated with Gag 181-189 CM9 escape (SIVmac239-2V) by site-directed mutagenesis of SIVmac239 plasmid DNA using the QuikChange XL kit (Stratagene, La Jolla, CA) and generated a virus stock as previously described (2) . Following intravenous infection of a Mamu-A1*001:01-positive rhesus macaque, r98003, with 100 ng Gag p27 CA , SIVmac239-2V replicated efficiently, peaking at 3.96 ϫ 10 7 viral RNA (vRNA) copies/ml plasma at 10 days postinfection (d.p.i.), as measured by quantitative reverse transcription-PCR (RT-PCR) using previously described techniques (11) (Fig. 1A) . This level of viral replication is consistent with a large body of data collected from wild-type SIVmac239-infected Mamu-A1*001:01-positive rhesus macaques (12, 13) . Additionally, major histocompatibility complex (MHC) class I tetramer staining of freshly isolated peripheral blood mononuclear cells (PBMC) revealed that SIVmac239-2V elicited a strong CD8 TL response against Gag 181-189 CM9, with 3.5% of all circulating CD8 TL tar-geting this epitope at 14 d.p.i. (Fig. 1A) . Importantly, this Gag 181-189 CM9-specific CD8 TL response remained at high frequency in r98003 through 15 weeks p.i. (w.p.i.).
Next, we monitored viral evolution within gag by performing Roche/454 pyrosequencing on plasma samples as described previously (8) . Unexpectedly, instead of observing rapid, acute-phase escape of Gag 181-189 CM9, we detected high-frequency reversions of both the I 161 V and I 206 V compensatory mutations (Fig. 1B) . The frequency of revertant viruses in plasma increased through 8.5 w.p.i., when 98.3% of plasma virus sequences were wild-type SIVmac239 at I 206 and 84% were wild-type SIVmac239 at I 161 . Subsequently, we detected two Gag 181-189 CM9 escape mutations, C 181 G and T 182 A, only after the I 206 V compensatory mutation had reverted almost entirely to wild type, with I 206 V present in only 1.7% of all pyrosequencing reads (Fig. 1B) . The C 181 G mutation is rare but is a previously described Gag 181-189 CM9 escape mutation that also associates with the I 161 V and I 206 V compensatory mutations in Mamu-A1*001:01-positive, SIVmac239-infected rhesus macaques (8, 9) . These three mutations increased in frequency together and were tightly linked, with 87% of sequences containing one or both escape mutations also harboring the I 206 V compensatory mutation (data not shown). While we failed to observe rapid acute-phase CD8 TL escape, r98003 did manifest the earliest Gag181-189CM9 escape mutations of nine Mamu-A1*001:01-positive rhesus macaques that we have investigated previously via Roche/454 pyrosequencing (8) (Fig. 1C) .
The SIV compensatory mutations Gag I 161 V and I 206 V do not always revert following transmission to Mamu-A1*001:01-negative rhesus macaques. Given the surprising reversion of the compensatory mutations following infection of a naive host, we next investigated additional animals infected with SIVmac239 harboring the preengineered I 161 V and I 206 V mutations. Friedrich et al. previously described three rhesus macaques infected with 3XSIVmac239, a virus encoding the Gag 181-189 CM9 escape mutation T 182 A and the two compensatory substitutions I 161 V and I 206 V (2). We Roche/454 pyrosequenced virus from plasma samples obtained from these three animals, spanning the first 8 months of infection, to make direct comparisons with virus sequences from r98003 and to glean additional insight into why SIVmac239-2V reverted at positions I 161 V and I 206 V before Gag 181-189 CM9 escape. Two of these rhesus macaques were Mamu-A1*001:01 negative (r98020, r96115), and one was Mamu-A1*001:01 positive (r97089). The 3XSIVmac239 circulating in r97089 retained all three (I 161 V, T 182 A, and I 206 V) preengineered mutations, most likely due to low-frequency Mamu-A1*001:01-restricted, Gag 181-189 CM9-specific CD8 TL (14) (Fig. 2A) . In con- trast, 3XSIVmac239 evolution diverged between the two Mamu-A1*001:01-negative animals. The 3XSIVmac239 circulating in r96115 reverted completely to wild type at all three positions (I 161 , T 182 , and I 206 ) by 24 w.p.i., supporting our data from r98003 (Fig.  2B) . Surprisingly, 3XSIVmac239 in r98020 reverted completely to wild type at position T 182 by 24 w.p.i. but maintained the compensatory mutations I 161 V and I 206 V in 100% of sequence reads through 30 w.p.i. (Fig. 2C ). This finding is in contrast to our data from r98003 and r96115, in which compensatory mutations I 161 V and I 206 V reverted in the absence of a Gag 181-189 CM9 escape mutation (Fig. 1B  and 2B ). The downstream Gag mutation A 312 P stabilizes SIV containing compensatory mutations I 161 V and I 206 V in the absence of a Gag 181-189 CM9 escape mutation. The divergent viral evolution between r98003, r96115, and r98020 raised the possibility that a tertiary mutation was maintaining viral fitness while allowing for the retention of the I 161 V and I 206 V compensatory mutations. To test this hypothesis, we analyzed Gag sequences from a cohort of 25 chronically SIV-infected rhesus macaques, including r98003, r97089, and r98020, at various time points postinfection (11 Mamu-A1*001:01-positive, 14 Mamu-A1*001:01-negative macaques) using consensus Sanger sequencing as previously described (15) . We found that viral sequences from five of seven SIVmac239-infected, Mamu-A1*001:01-positive animals contained mutations I 161 V, T 182 A/C, I 206 V, and a downstream mutation, Gag A 312 P (Fig. 3A) . Virus from the two remaining Mamu-A1*001:01-positive animals (r98001 and r99084) harbored the A 312 P mutation alone, suggesting that this mutation can precede the I 161 V, T 182 A/C, and I 206 V mutations. In contrast, none of these mutations were observed in Mamu-A1*001:01-negative animals (Fig. 3A) . Thus, it appeared that A 312 P was associated with Gag 181-189 CM9 escape. Next, we examined the association of A 312 P with the maintenance of the I 161 V and I 206 V compensatory mutations following transmission of our engineered viruses to naive hosts. In two out of the three Mamu-A1*001:01-positive animals infected with 3XSIVmac239 (r97089 and r97035), the A 312 P mutation arose following infection, which again suggested that A 312 P stabilizes the Gag 181-189 CM9 escape-associated compensatory mutations (Fig. 3B) . In the two Mamu-A1*001:01-negative animals infected with 3XSIVmac239 (r98020 and r96115), A 312 P was present only in r98020, where the compensatory mutations persisted in the absence of Gag 181-189 CM9 escape. In r98003, the Mamu-A1*001:01-positive animal infected with SIVmac239-2V, the lack of A 312 P was associated with reversion of the compensatory mutations to wild type (Fig. 3C) .
To further test if the tertiary mutation A 312 P would stabilize the I 161 V and I 206 V compensatory mutations during reversion of Gag 181-189 CM9 epitope mutations, we infected a Mamu-A1*001: 01-negative animal, r00033, with virus from rh1937 that contained the T 182 C Gag 181-189 CM9 escape mutation, the I 161 V and I 206 V compensatory mutations, and the tertiary A 312 P mutation (Fig. 3A and D) . In agreement with our previous observations, the A 312 P mutation stabilized the I 161 V and I 206 V compensatory mutations, while the T 182 C escape mutation reverted to wild type (Fig. 3D) . Cumulatively, these data suggest that A 312 P is necessary for the maintenance of I 161 V and I 206 V compensatory mutations in the absence of Gag 181-189 CM9 escape.
Gag A 312 P is a bona fide compensatory mutation. We observed that A 312 P consistently associated with the Gag 181-189 CM9 escape-associated compensatory mutations, but we wanted to further assess the compensatory characteristics of the A 312 P mutation. We first investigated the possibility that A 312 P could be a CD8 TL escape mutation but found no evidence of T cells targeting this region of Gag. Using in silico binding algorithms (http://www .cbs.dtu.dk/services/NetMHC/) we found that no 8-, 9-, or 10-mer peptides between SIVmac239 Gag residues 301 and 323 are predicted to bind Mamu-A1*001:01 with physiologically relevant affinity (50% inhibitory concentration [IC 50 ] Յ 500 nM) (16) . In addition, we detected no CD8 TL which also had circulating virus harboring the A 312 P mutation (Fig. 4A, red symbols) . These results, in combination, support the conclusion that CD8 TL pressure does not drive the emergence of A 312 P in Mamu-A1*001:01-positive animals.
Next, we performed an in vitro SIVmac239 replication assay to compare the growth kinetics and levels of stability of viruses containing the I 161 V, I 206 V, and A 312 P mutations. We engineered two SIVmac239 mutants (in addition to SIVmac239-2V) containing the I 161 V, I 206 V, and A 312 P mutations together (SIVmac239-2V-P) or the A 312 P mutation alone (SIVmac239-P). We infected separate cultures of staphylococcal-enterotoxin B-stimulated rhesus macaque CD4 ϩ T cells with 2 ϫ 10 7 virus particles of either SIVmac239 or a mutant virus in complete medium containing 100 IU interleukin 2 (IL-2)/ml and cultured them for 7 days. On days 7 and 14, virus-containing cell supernatant was diluted 1:4 with medium and used to infect additional activated CD4 ϩ T cells. We compared the frequencies of infected targets for each mutant virus on days 14 and 21 by intracellular Gag p27 antibody staining, normalizing to the frequency of SIVmac239-infected targets (Fig.  4B) . Mutant viruses showed replication kinetics similar to that of SIVmac239 over the first 14 days but exhibited a higher replicative capacity by day 21. We Sanger sequenced the mutant viruses from our replication assay at day 14 and found that SIVmac239-2V, but not SIVmac239-2V-P, showed a prominent double peak indicating reversion of the I 206 V mutation (Fig. 4C) .
Finally, we generated structural models of the SIVmac239 capsid (CA) hexamer as previously described (17) and assessed locations and potential interactions of the I 161 , T 182 , I 206 , and A 312 amino acid residues (Fig. 4D, top) . The I 161 residue is found in helix 1 of CA, and its side chain protrudes into helix 4, where the I 206 residue is located, supporting the observed linkage between the I 161 V and I 206 V mutations. Importantly, the A 312 residue lies within CA helix 9, near the I 206 -containing helix 4 of the adjacent CA monomer (Fig. 4D, bottom) . Thus, SIVmac239 CA structural data suggest that the A 312 P mutation may influence the intermolecular interactions and stability of the CA hexamer. In support of this hypothesis, we consistently detected higher levels of intracellular Gag p27 CA in cells infected with viruses containing the A 312 P mutations (Fig. 4E) . Taken together, our structural and in vitro sequencing data strongly support our conclusion that A 312 P is a tertiary compensatory mutation that stabilizes SIVmac239 expressing the Gag 181-189 CM9-associated compensatory mutation.
The association of A 312 P with the I 161 V and I 206 V compensatory mutations has not previously been described in studies of Gag 181-189 CM9 escape but is not altogether an unexpected finding. In fact, the data presented herein contribute to a growing body of evidence that HIV and SIV variation within Gag is highly organized, both in terms of mutation kinetics and constrained patterns of escape (18) (19) (20) . These structural restraints have contributed to the identification of Gag as a premier target for T cell-based HIV vaccine design.
As HIV circulates in human populations, there is concern that CD8 TL epitopes will be "lost" as escape substitutions accumulate in transmitted viruses. While the finding that such escape mutations frequently revert in the absence of selecting HLA alleles ameliorates this concern, the persistence of compensatory mutations in transmitted viruses may facilitate rapid escape when the virus next encounters CD8 TL restricted by the selecting HLA molecule. However, our data indicate that transmitted compensatory mutations do not necessarily facilitate rapid, acute-phase immune escape from CD8 TL responses. Further study of additional compensatory mutations, in terms of their frequency in circulating HIV strains and their effect on posttransmission CD8 TL responses, is warranted to fully understand their impact on the adaptation of HIV to HLA molecules present at high frequency within the human population.
